The mean immunofluorescence intensities of total CB1 and phosphorylated CB1 were analyzed at distinct times (2, 4, and 8 weeks) of diabetes progression vs. controls (i.e., healthy rats) as shown in Figure 2. The gene discussed is CNR1; the disease is diabetes mellitus.